Clinical Trials Logo

Toxemia clinical trials

View clinical trials related to Toxemia.

Filter by:

NCT ID: NCT03249597 Completed - Sepsis Clinical Trials

Predict Sepsis; the Predictive Value of Bedside Measures in the Ambulance

Start date: April 3, 2017
Phase:
Study type: Observational

Sepsis is a condition with a high mortality. Septic patients are frequently difficult to identify because of their non-specific presentations. There is also a low sensitivity of clinical judgment among health care personnel, and of existing screening tools, which are in turn typically based on vital parameters. Despite prior research, no unique sepsis biomarker has been identified so far. There is a need for new strategies to identify sepsis which do not rely on vital parameters and traditional laboratory blood tests alone. The hypothesis of the investigators is that a combination of clinical variables measurable in the ambulance can be used to predict sepsis. The aim of the current study is to determine the predictive value of keywords related to symptom presentation, vital parameters and point-of-care (POC) blood tests, alone and in combination, with respect to the outcome sepsis. The study is performed in the Stockholm ambulance setting from April 2017. A total of 956 adult non-trauma patients will be included.

NCT ID: NCT03249246 Completed - Sepsis Clinical Trials

Epidemiology of Sepsis in Turkish ICUs.

Start date: January 27, 2016
Phase: N/A
Study type: Observational

The prevalence and mortality of sepsis in Turkey is not know at large. Turkish Society of Intensive Care Medicine, Sepsis Study Group conducted a multi-centre,point prevalence survey to determine the prevalence, causative micro-organisms and outcome of sepsis in Turkish ICUs.

NCT ID: NCT03246893 Completed - Septic Shock Clinical Trials

Efficacy of HFNC Versus NIV for Prevent Reintubation in Sepsis Patients

Start date: May 1, 2017
Phase: N/A
Study type: Interventional

Post extubation respiratory failure occur in 30% of extubated patients. More than 50% of them required reintubation. Noninvasive positive pressure ventilation (NIV) had been reported as an effective tool to prevent post extubation respiratory failure. Recently, high flow oxygen nasal cannula (HFNC) had been successfully used to prevent post extubation respiratory failure and prevent reintubation in comparable with NIV among post cardiothoracic surgery and high risk for reintubated patients. There was no information about HFNC versus NIV in prevention of reintubation among severe sepsis or septic shock patients.

NCT ID: NCT03244293 Recruiting - Sepsis, Severe Clinical Trials

Bispectral Index (BIS) for Classification of Procalcitonin (PCT) Sepsis Grades in Critically Ill Patients With Sepsis

BIS6
Start date: January 1, 2014
Phase:
Study type: Observational

To evaluate the discriminative power of BIS monitoring to classify the degree of mental state associated with the PCT graded sepsis cascade, and to assess its utility for monitoring the improvement or deterioration of sepsis.

NCT ID: NCT03238742 Completed - Sepsis Clinical Trials

The Efficacy of Xuebijing Injection on Sepsis

Start date: October 20, 2017
Phase: Phase 4
Study type: Interventional

The Efficacy of Xuebijing Injection in Adult Patients with Sepsis

NCT ID: NCT03237728 Completed - Sepsis Clinical Trials

Study of Multiple-dose Kukoamine B Mesilate in Sepsis Patients

Start date: July 28, 2017
Phase: Phase 1
Study type: Interventional

Phase I study of multiple-dose Kukoamine B Mesilate in Sepsis Patients

NCT ID: NCT03235193 Completed - Sepsis Clinical Trials

Predictive algoRithm for EValuation and Intervention in SEpsis

PREVISE
Start date: July 1, 2017
Phase: N/A
Study type: Interventional

In this prospective study, the ability of a machine learning algorithm to predict sepsis and influence clinical outcomes, will be investigated at Cabell Huntington Hospital (CHH).

NCT ID: NCT03231956 Recruiting - Sepsis Clinical Trials

CLEAR Sepsis Clinical Study

CLEAR Sepsis
Start date: June 29, 2017
Phase:
Study type: Observational

To investigate the relationship between initial ClearSight™ derived hemodynamic parameters and outcomes (death, ongoing organ dysfunction or delayed ICU admission) in patients with acute infection and possible sepsis, with a focus on venous blood lactate (< 2.0, 2.0-3.9, and ≥ 4.0 mmol/dL) and hemodynamic subgroups, using ED patients presenting with minor infections or asthma/COPD exacerbations as controls (henceforth referred to as Sepsis Mimic Group).

NCT ID: NCT03226366 Completed - Sepsis Clinical Trials

Effect of Emergency Department Care Reorganization on Door-to-antibiotic Times for Sepsis (LDS SWARM)

Start date: May 16, 2015
Phase:
Study type: Observational

Sepsis is a common syndrome resulting from a dysregulated response to infection. The timing of antibiotic initiation is an important determinant of outcomes for patients presenting to the emergency department with sepsis. The potential effect of care reorganization on very early care for sepsis is unknown. This study will investigate whether multidisciplinary coordination of the initial patient evaluation in the emergency department influences door-to-antibiotic time for septic patients.

NCT ID: NCT03214913 Not yet recruiting - Sepsis Clinical Trials

Controlled Fluid Resuscitation in Sepsis

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

To evaluate two different strategy of fluid resuscitation in sepsis patients